X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Cell Therapy Companies

This report lists the top Cell Therapy companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cell Therapy industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Cell Therapy Top Companies

  1. Pharmicell

  2. CORESTEM

  3. Chiesi Farmaceutici

  4. Tego Science

  5. Anterogen Co., Ltd.

*Disclaimer: Top companies sorted in no particular order

Cell Therapy Market Major Players

Cell Therapy Market Concentration

Cell Therapy  Market Concentration

Cell Therapy Company List

                              • Anterogen Co. Ltd

                              • Tego Science

                              • Chiesi Farmaceutici SpA

                              • Corestem Inc.

                              • Pharmicell Co. Ltd

                              • Fibrocell Technologies Inc.

                              • Nipro Corporation

                              • MEDIPOST Co. Ltd

                              • TiGenix (Takeda Pharmaceuticals)

                              • Stempeutics Research Pvt. Ltd

                              • Gilead Sciences Inc. (Kite Pharma Inc.)

                              • Allogene Therapeutics Inc.

                              • Novartis AG

                              • Vericel Corporation

                              • Organogenesis Inc.


                          Specific to Cell Therapy Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)